Ammar A, Cibert C, Bertoli A M, Tsilivakos V, Jasmin C, Georgoulias V
Unité d'Oncogénèse Appliquée, Institut National de la Santé et de la Recherche Médicale Unité 268, Hôpital Paul Brousse, Villejuif, France.
J Clin Invest. 1991 Jun;87(6):2048-55. doi: 10.1172/JCI115235.
Adherent cells from human immunodeficiency virus (HIV)-infected subjects but not from normal blood donors, patients with Gram-positive or -negative bacteremia, active tuberculosis, toxoplasmosis, pulmonary aspergillosis, and cytomegalovirus infection produce spontaneously an activity which inhibits alpha chain of interleukin-2 (Tac) expression and interleukin 2 (IL-2) production by normal activated T cells and IL-2 production by these cells. A similar biologic activity was detected in culture supernatants of in vitro HIV-I-infected normal adherent and leukemic U937 cells. Tac-inhibitory activity is not cytotoxic and it could be detected in serum-free conditioned media. Recombinant granulocyte/macrophage colony-stimulating factor and phorbol myristate acetate stimulation of patients' and normal adherent cells did not enhance specifically the production of the Tac inhibitor. Biologically active conditioned media did not contain infectious virus as well as secreted p24, gp120 viral proteins; the biologic activity could not be abolished by anti-p24, anti-gp120, and anti-nef monoclonal antibodies or human purified polyclonal anti-HIV IgG. Gel filtration of conditioned media followed by anion exchange chromatography resulted in a 1,200-fold degree of purification and revealed that the biologically active molecule was cationic. Sodium dodecyl sulfate polyacrylamide gel electrophoresis of this fraction and gel elution of the proteins showed that the biologic activity was associated with a 29-kD protein which was distinct from alpha- or gamma-interferon, tumor necrosis factor-alpha, and prostaglandin E2. The above findings demonstrate the production of inhibitory factor(s) during HIV infection, which might be involved in the pathogenesis of the patients' immune defect.
来自人类免疫缺陷病毒(HIV)感染受试者而非正常献血者、革兰氏阳性或阴性菌血症患者、活动性肺结核患者、弓形虫病患者、肺曲霉菌病患者和巨细胞病毒感染患者的贴壁细胞,能自发产生一种活性物质,该物质可抑制正常活化T细胞的白细胞介素-2(IL-2)α链(Tac)表达及IL-2产生,以及这些细胞的IL-2产生。在体外感染HIV-1的正常贴壁细胞和白血病U937细胞的培养上清液中也检测到了类似的生物活性。Tac抑制活性无细胞毒性,且可在无血清条件培养基中检测到。重组粒细胞/巨噬细胞集落刺激因子和佛波酯对患者及正常贴壁细胞的刺激,并未特异性增强Tac抑制剂的产生。具有生物活性的条件培养基中不含传染性病毒以及分泌的p24、gp120病毒蛋白;抗p24、抗gp120和抗nef单克隆抗体或人纯化多克隆抗HIV IgG均不能消除该生物活性。对条件培养基进行凝胶过滤,随后进行阴离子交换层析,得到了1200倍的纯化程度,并表明具有生物活性的分子是阳离子性的。对该组分进行十二烷基硫酸钠聚丙烯酰胺凝胶电泳及蛋白质凝胶洗脱显示,生物活性与一种29-kD的蛋白质相关,该蛋白质与α或γ干扰素、肿瘤坏死因子-α和前列腺素E2不同。上述发现表明,HIV感染期间会产生抑制因子,这可能与患者免疫缺陷的发病机制有关。